CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Goldother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03389906
NCT03389906N/ACompleted
CompareCT.gov

Inflammation Impact on Pain in Patients With Knee Osteoarthritis

Sten Rasmussen, MD, PhD·interventional·Posted Jan 4, 2018·Updated Aug 12, 2021

In Brief

A clinical study evaluating Gold for Inflammation and Osteo Arthritis Knee. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The aim of this study is to use gold particles as a model compound to modulate specifically and selectively the function of macrophages and mast cells and investigate how this modulates pain and pain sensitization in the osteoarthritic knee assessed by mechanistic pain assessment technologies

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation, Osteo Arthritis Knee
CountriesDenmark
CollaboratorsAalborg University

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 4, 2018
Enrollment StartDec 1, 2017
Primary CompletionDec 1, 2018
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.5 years ago

Interventions

Goldother

Approximately 72000, 20-40 my-meter diameter, sterilised gold particles (=20 mg) will be provided in vials (The Berlock® Gold Implants). 5-10 ml of synovial fluid is aspirated (20G needle) from most affected OA-knee. The vial of gold particles are mixed with the synovial fluid, and the mix of gold and synovial fluid is injected intra-articularly into the patients knee.